Duke biotech spin-out Argos wants to treble workforce and build a new facility.
Argos Therapeutics, a biotech spin-out of Duke University, is planning to build a new biomanufacturing facility in the Research Triangle Park. At the same time, the company has announced it will grow its staff by 230, trebling its current workforce.
The facility will be 100,000 square foot and be supported with $9.5m in incentives by the North Carolina’s Department of Commerce ($7.1m) and the North Carolina Biotechnology Centre ($200,000, via the Department of Commerce’s investment). Durham County and the city…
